JCGGDB TOP GlycoScience Protocol Online Database

Enzyme assay of sulfotransferases for chondroitin sulfate/dermatan sulfate
Text Search

Enzyme assay of sulfotransferases for chondroitin sulfate/dermatan sulfate

Authors:
Introduction Protocol References Credit lines
Category
Glycosyltransferases & related proteins
Protocol Name

Enzyme assay of sulfotransferases for chondroitin sulfate/dermatan sulfate

Authors
Habuchi, Osami
Advanced Medical Research Center, Aichi Medical University
KeyWords
Reagents

[35S]PAPS (10,000 cpm/pmol)

Chondroitin sulfate A from whale cartilage (Seikagaku Corp., Tokyo, Japan)

Dermatan sulfate from pig skin (Seikagaku Corp.)

pFLAG-CMV-2 plasmid (Sigma-Aldrich, St. Louis, MO)

COS-7 cells

FLAG M2 antibody-conjugated agarose (Sigma-Aldrich)

Clearsol (Nacalai Tesque Inc., Kyoto, Japan)

Instruments

Desalting column (1 × 10 cm) filled with Sephadex G-25 superfine

HPLC system

Partisil-10 SAX column (4.6 mm × 25 cm) (Whatman International Ltd., Kent, UK)

Liquid scintillation counter

Methods
1.

Enzyme assay of Sulfotransferases for chondroitin sulfate/dermatan sulfate

1) 

 Prepare the recombinant enzymes.

Comment 1
2) 

 Prepare the acceptor substrate, chondroitin sulfate A and dermatan sulfate.

Comment 1
3) 

 Prepare the donor substrate, [35S]PAPS.

Comment 1
4) 

 Prepare the reaction mixture (50 μL). For GalNAc4S-6ST, the reaction mixtures contain 50 mM imidazole-HCl buffer (pH 6.8), 10 mM CaCl2, 20 mM reduced glutathione, 0.5 μmol/mL (as galactosamine) chondroitin sulfate A, 1 μM [35S]PAPS (about 5.0 × 105 cpm/50 μL). and 2 to 5 μL of the recombinant enzyme. For 2OST, 50 mM imidazole-HCl buffer (pH 6.8), 0.0052% protamine chloride, 0.5 μmol/mL (as galactosamine) chondroitin sulfate A, dermatan sulfate or desulfated dermatan, 1 μM [35S]PAPS (about 5.0 × 105 cpm/50 μL), and 2 to 5 μL of the recombinant enzyme.

Comment 0
5) 

 Incubate at 37˚C for 20 min.

Comment 0
6) 

 Terminate the reaction by immersing the reaction tubes in a boiling water bath for 1 min.

Comment 0
7) 

 Add 50 nmol CS-A as carrier and three volumes of ethanol containing 1% (w/v) potassium acetate. The mixtures are stirred well and placed on ice for 30 min.

Comment 0
8) 

 Collect the precipitate with centrifugation at 10,000 rpm for 10 min and dissolve the precipitate in 70 μL water.

Comment 0
9) 

 Inject 50 μL of the solution into a desalting column equilibrated with 0.1 M NH4HCO3 at the flow rate of 2 mL/min, and collect the void fractions.

Comment 1
10) 

 Mix an aliquot of the [35S]glycosaminoglycan fraction with Clearsol and determine the radioactivity by a liquid scintillation counter.

Comment 0
11) 

 Digest the [35S]glycosaminoglycan with chondroitinase ACII or chondroitinase ABC.

Comment 1
12) 

 Inject the digests to Partisil-10 SAX column equilibrated with 5 mM KH2PO4 and separate digestion products.

Comment 1
13) 

 For GalNAc4S-6ST, determine the radioactivity of GalNAc (4,6-bisSO4), ∆HexA-GalNAc(4, 6-bisSO4) and GalNAc (4,6-bisSO4)-GlcA(2SO4)-GalNAc(6SO4).

For 2OST, determine the radioactivity of ∆HexA(2SO4)-GalNAc(6SO4) when chondroitin sulfate is used as the acceptor, ∆HexA(2SO4)-GalNAc(4SO4) when dermatan sulfate is used as the acceptor, and ∆HexA(2SO4)-GalNAc when desulfated dermatan sulfate is used as the acceptor.

Comment 1
Copyrights Creative Commons License   Attribution-Non-Commercial Share Alike
This work is released underCreative Commons licenses
Date of registration:2014-07-29 16:23:25
©2010 - 2023 Ritsumeikan University, AIST & JCGGDB. All Rights Reserved